Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marjut Nätynki

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Basic & Clinical Pharmacology & Toxicology|April 19, 2018
Development of Molecular Therapies for Venous MalformationsJaakko Kangas, Marjut Nätynki, Lauri Eklund
Biochemical and Biophysical Research Communications|July 29, 2025
PALB2 mutations increase oncogenic properties of breast epithelial cells by enhancing JAM3 and PARVB expressionHanna Tuppurainen, Marjut Nätynki, Niina Laurila, et al.
Human Molecular Genetics|August 31, 2015
Common and specific effects of TIE2 mutations causing venous malformationsMarjut Nätynki, Jaakko Kangas, Ilkka Miinalainen, et al.
Cellular and Molecular Life Sciences : CMLS|April 10, 2024
PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFβ signalingHanna Tuppurainen, Niina Laurila, Marjut Nätynki, et al.
Human Molecular Genetics|May 2, 2013
Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFBMelanie Uebelhoer, Marjut Nätynki, Jaakko Kangas, et al.
Angiogenesis|January 8, 2022
PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosisHarri Elamaa, Mika Kaakinen, Marjut Nätynki, et al.
Elife|November 17, 2018
Angiopoietin-4-dependent venous maturation and fluid drainage in the peripheral retinaHarri Elamaa, Minna Kihlström, Emmi Kapiainen, et al.
Journal of Cell Science|February 24, 2012
Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responsesRiikka Pietilä, Marjut Nätynki, Tuomas Tammela, et al.
The Journal of Investigative Dermatology|August 14, 2016
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) MutationsJulie Soblet, Jaakko Kangas, Marjut Nätynki, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Basic & Clinical Pharmacology & Toxicology|April 19, 2018
Development of Molecular Therapies for Venous MalformationsJaakko Kangas, Marjut Nätynki, Lauri Eklund
Biochemical and Biophysical Research Communications|July 29, 2025
PALB2 mutations increase oncogenic properties of breast epithelial cells by enhancing JAM3 and PARVB expressionHanna Tuppurainen, Marjut Nätynki, Niina Laurila, et al.
Human Molecular Genetics|August 31, 2015
Common and specific effects of TIE2 mutations causing venous malformationsMarjut Nätynki, Jaakko Kangas, Ilkka Miinalainen, et al.
Cellular and Molecular Life Sciences : CMLS|April 10, 2024
PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFβ signalingHanna Tuppurainen, Niina Laurila, Marjut Nätynki, et al.
Human Molecular Genetics|May 2, 2013
Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFBMelanie Uebelhoer, Marjut Nätynki, Jaakko Kangas, et al.
Angiogenesis|January 8, 2022
PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosisHarri Elamaa, Mika Kaakinen, Marjut Nätynki, et al.
Elife|November 17, 2018
Angiopoietin-4-dependent venous maturation and fluid drainage in the peripheral retinaHarri Elamaa, Minna Kihlström, Emmi Kapiainen, et al.
Journal of Cell Science|February 24, 2012
Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responsesRiikka Pietilä, Marjut Nätynki, Tuomas Tammela, et al.
The Journal of Investigative Dermatology|August 14, 2016
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) MutationsJulie Soblet, Jaakko Kangas, Marjut Nätynki, et al.
Pageof 1